Recurrence of Bladder Cancer After Transurethral Resection With Hexvix

NCT00785694 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Rejected ethics approval in UK and Holland

Conditions

Bladder Cancer

Interventions

DRUG: hexaminolevulinate

Sponsor

GE Healthcare